The Europe Clinical Decision Support Systems Market would witness market growth of 9.8% CAGR during the forecast period (2021-2027).
Computerized clinical decision support systems are a paradigm evolution in today's healthcare. CDSS are utilized to assist clinicians with their difficult decision-making. CDSS has developed rapidly since its introduction in the 1980s. They are now widely administered through electronic medical records and other automated clinical procedures, which has been made possible by the growing global usage of advanced electronic medical records. Despite these enhancements, there are still unknowns about the effect of CDSS on providers, patient outcomes, and costs.
Hospitals, diagnostic centers, and clinics are demonstrating an interest in clinical decision support systems to reduce pharmaceutical prescription errors, adverse drug event monitoring, and other medical errors. The growing desire for lower healthcare costs, the need to improve service quality, and technical improvements in healthcare IT in hospitals are all expected to drive the clinical decision support systems (CDSS) market forward.
Healthcare that is based on the most up-to-date clinical data can result in high quality care. Evidence-based guidelines are potentially useful tools, yet they are frequently disregarded by practitioners. A CDSS is a technology that uses patient-specific data to give relevant medical knowledge at the point of service. It is seen as a critical quality-improvement initiative, and EU member states are encouraged to invest in it as a top priority.
The Germany market dominated the Europe Clinical Decision Support Systems Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $513.8 million by 2027. The UK market would showcase a CAGR of 9% during (2021 - 2027). Additionally, The France market is experiencing a CAGR of 10.6% during (2021 - 2027).
Based on Component, the market is segmented into Services, Hardware, and Software. Based on Product, the market is segmented into Standalone CDSS, Integrated CDSS with CPOE & E.H.R., Integrated E.H.R. with CDSS, and Others. Based on Delivery Mode, the market is segmented into On-premise Systems, Web-based Systems, and Cloud-based Systems. Based on Application, the market is segmented into Drug Allergy Alerts, Drug-drug Interactions, Clinical Guidelines, Drug Dosing Support, Clinical Reminders, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Clinical Decision Support Systems Market Size will Hit $8.2 Billion by 2027, at a CAGR of 10.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Siemens Healthineers AG (Siemens AG), Cerner Corporation (Oracle Corporation), AllScripts Healthcare Solutions, Inc., General Electric (GE) Co. (GE Healthcare), NextGen Healthcare, Inc., Athenahealth, Inc. (Veritas Capital), Epic Systems Corporation, eClinicalWorks LLC, Change Healthcare, Inc., and Zynx Health, Inc. (Hearst Communications, Inc.).
By Component
By Product
By Delivery Mode
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
